SmartGene services to be used for the local detection of SARS-CoV-2 variants and national surveillance across France.

SmartGene announces that its application services for genetic analysis of Coronaviruses will be used by scientific teams supported by France's ANRS Emerging Infectious Diseases Agency (ANRS-MIE).  SmartGene's technology will enable immediate detection locally of SARS-CoV-2 variants of concern and real-time surveillance nationally of the evolution of the virus across France.

• To read the announcement, please click here.
• To learn more about our offerings regarding Coronaviruses, please view our website content here.
• To contact us, please use the following link:  This email address is being protected from spambots. You need JavaScript enabled to view it.